| MeSH term | MeSH ID | Detail |
|---|---|---|
| Bronchitis | D001991 | 6 associated lipids |
| Intermittent Claudication | D007383 | 6 associated lipids |
| Purpura, Thrombotic Thrombocytopenic | D011697 | 6 associated lipids |
| Infant, Premature, Diseases | D007235 | 7 associated lipids |
| Biliary Tract Neoplasms | D001661 | 7 associated lipids |
| Femoral Fractures | D005264 | 7 associated lipids |
| Raynaud Disease | D011928 | 7 associated lipids |
| Bronchopneumonia | D001996 | 7 associated lipids |
| Tachycardia | D013610 | 7 associated lipids |
| Dyslipidemias | D050171 | 7 associated lipids |
| Keratitis | D007634 | 7 associated lipids |
| Glomerulonephritis, IGA | D005922 | 7 associated lipids |
| Disseminated Intravascular Coagulation | D004211 | 7 associated lipids |
| Coronary Thrombosis | D003328 | 7 associated lipids |
| Varicose Veins | D014648 | 7 associated lipids |
| Behcet Syndrome | D001528 | 7 associated lipids |
| Agranulocytosis | D000380 | 7 associated lipids |
| Rhinitis, Allergic, Seasonal | D006255 | 7 associated lipids |
| Aortic Aneurysm | D001014 | 8 associated lipids |
| Lupus Nephritis | D008181 | 8 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Chen L et al. | Cyclooxygenase inhibition decreases nitric oxide synthase activity in human platelets. | 1997 | Am. J. Physiol. | pmid:9362253 |
| Barton MH et al. | Effects of pentoxifylline infusion on response of horses to in vivo challenge exposure with endotoxin. | 1997 | Am. J. Vet. Res. | pmid:9361896 |
| Baskett A et al. | Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses. | 1997 | Am. J. Vet. Res. | pmid:9361895 |
| Lahoz C et al. | Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. | 1997 | Eur. J. Clin. Invest. | pmid:9352251 |
| Neupert W et al. | Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases. | 1997 | Br. J. Pharmacol. | pmid:9351505 |
| Supanz S et al. | Effects of the novel thromboxane (TXA2) receptor antagonist linotroban on inulin and para-aminohippuric acid clearances in the conscious male and female rat. | 1997 | Arzneimittelforschung | pmid:9342416 |
| Zahavi M and Zahavi J | Concomitant in vitro platelet hypofunction and increased thromboxane B2 (TXB2) generation and enhanced in vivo platelet activation. A distinct syndrome in thrombosis? | 1997 | Eur. J. Haematol. | pmid:9338626 |
| Chavali SR et al. | Decreased production of interleukin-1-beta, prostaglandin-E2 and thromboxane-B2, and elevated levels of interleukin-6 and -10 are associated with increased survival during endotoxic shock in mice consuming diets enriched with sesame seed oil supplemented with Quil-A saponin. | 1997 | Int. Arch. Allergy Immunol. | pmid:9338609 |
| Hashimoto Y et al. | Characteristics of protein kinase C-independent exocytosis in human platelets. | 1997 | Thromb. Res. | pmid:9336873 |
| Matrougui K et al. | Impaired nitric oxide- and prostaglandin-mediated responses to flow in resistance arteries of hypertensive rats. | 1997 | Hypertension | pmid:9336397 |
| Moser L et al. | ACE inhibitor effects on platelet function in stages I-II hypertension. | 1997 | J. Cardiovasc. Pharmacol. | pmid:9335405 |
| Uteshev DB and Uteshev BS | [Adhesive molecules as drugs and objects of pharmacological effect in myocardial ischemia and reperfusion]. | 1997 May-Jun | Eksp Klin Farmakol | pmid:9324410 |
| Swails WS et al. | Effect of a fish oil structured lipid-based diet on prostaglandin release from mononuclear cells in cancer patients after surgery. | 1997 Sep-Oct | JPEN J Parenter Enteral Nutr | pmid:9323688 |
| Berlin I et al. | [Comparison between effects of morning and evening administration of effervescent calcium carbasalate (equivalent of 160 mg aspirin) on the gastroduodenal mucosa in healthy volunteers]. | 1997 | Pathol. Biol. | pmid:9309270 |
| Tanaka M et al. | Effects of a thromboxane synthetase inhibitor (OKY-046) in an ischemia-reperfusion model of intrauterine growth retardation in Sprague-Dawley rats. | 1997 | Biol. Neonate | pmid:9303217 |
| Abate A et al. | Inhibition of mediator release from anaphylactic guinea pig hearts by the novel phospholipase A2 inhibitor 3-(4-octadecylbenzoyl) acrylic acid. | 1997 | Inflamm. Res. | pmid:9297549 |
| Trang LE et al. | Levels of prostaglandins F2 alpha and E2 and thromboxane B2 in joint fluid in rheumatoid arthritis. | 1977 | Scand. J. Rheumatol. | pmid:929121 |
| Cipollone F et al. | Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. | 1997 | Circulation | pmid:9286937 |
| Santillan-Doherty P et al. | Plasma thromboxane B2 concentrations and pulmonary vascular resistance during lung reperfusion. | 1997 Jul-Aug | J Invest Surg | pmid:9284000 |
| Freese R and Mutanen M | Alpha-linolenic acid and marine long-chain n-3 fatty acids differ only slightly in their effects on hemostatic factors in healthy subjects. | 1997 | Am. J. Clin. Nutr. | pmid:9280178 |